Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Top Cited Papers
- 20 February 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Chemistry
- Vol. 5 (3), 161-173
- https://doi.org/10.1038/nchem.1568
Abstract
Inhibition of protein-protein interactions (PPIs) represents a significant challenge because it is unclear how they can be effectively and selectively targeted using small molecules. Achieving this goal is critical given the defining role of these interactions in biological processes. A rational approach to inhibitor design based on the secondary structure at the interface is the focus of much research, and different classes of designed ligands have emerged, some of which effectively and selectively disrupt targeted PPIs. This Review discusses the relevance of PPIs and, in particular, the importance of a-helix-mediated PPIs to chemical biology and drug discovery with a focus on designing inhibitors, including constrained peptides, foldamers and proteomimetic-derived ligands. In doing so, key challenges and major advances in developing generic approaches for the elaboration of PPI inhibitors are highlighted. The challenges faced in developing such ligands as drug leads - and how criteria applied to these may differ from conventional small-molecule drugs - are summarized.Keywords
This publication has 139 references indexed in Scilit:
- Discovery of HIV fusion inhibitors targeting gp41 using a comprehensive α-helix mimetic libraryBioorganic & Medicinal Chemistry Letters, 2012
- Structural Basis of Bcl‐xL Recognition by a BH3‐Mimetic α/β‐Peptide Generated by Sequence‐Based DesignChemBioChem, 2011
- High Specificity in Protein Recognition by Hydrogen‐Bond‐Surrogate α‐Helices: Selective Inhibition of the p53/MDM2 ComplexChemBioChem, 2010
- Synthetic α‐Helix Mimetics as Agonists and Antagonists of Islet Amyloid Polypeptide AggregationAngewandte Chemie-International Edition, 2010
- N-Acylpolyamine inhibitors of HDM2 and HDMX binding to p53Bioorganic & Medicinal Chemistry, 2009
- High‐Resolution Structural Characterization of a Helical α/β‐Peptide Foldamer Bound to the Anti‐Apoptotic Protein Bcl‐xLAngewandte Chemie-International Edition, 2009
- β-Peptides with improved affinity for hDM2 and hDMXBioorganic & Medicinal Chemistry, 2009
- Contemporary strategies for the stabilization of peptides in the α-helical conformationCurrent Opinion in Chemical Biology, 2008
- Sequence-Based Design of α/β-Peptide Foldamers That Mimic BH3 DomainsAngewandte Chemie-International Edition, 2008
- Heterocyclic α-helix mimetics for targeting protein–protein interactionsBioorganic & Medicinal Chemistry Letters, 2007